| October 30, 2012 • Volume 9 / Number 21 |
The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.
- Featured Article: Study Urges Caution on Source of Unrelated Donor Stem Cell Transplants »
- Study Looks at Terminal Cancer Patients' Expectations of Chemotherapy »
- Imatinib May Help Treat Aggressive Lymphoma »
- Researchers Identify Possible Biomarker for Early-Stage Lung Cancer »
- In Mice, Combining Cancer Vaccine and Low-Dose Anti-Angiogenesis Drug Shows Promise against Breast Cancer »
- Building Momentum: NCI's Center for Global Health »
- A Conversation with Dr. Patrick Loehrer about Improving Cancer Care in Kenya »
- Tackling the Complexity of Genes and Environments in Cancer »
- Featured Clinical Trial: Safety of Stem Cell Transplants for HIV-Positive Cancer Patients »
Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov. |
No comments:
Post a Comment